The implant is designed for severe pathology associated with early onset scoliosis, according to a news release.
With breakthrough designation, the device’s development, assessment and review will be expedited.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.